Local Drug Use in Periodontics
Bacteria are the major etiologic factor of periodontitis, which exhibits inflammation and destruction of periodontal tissue. Aim of the periodontal treatment is elimination or reduction of periodontopathogens by means of mechanical instrumentation and oral hygiene instruction. Subgingival recolonization of periodontal pathogens was slowly occurred in a few months after mechanical treatment although well plaque control was performed. Local antimicrobial agents were introduced for periodontal therapy as an adjunctive treatment. It has low side effects to oral and non-oral sites and shows higher drug concentration in gingival crevicular fluid than those by systemic route. This review article included general principles to be considered of local drug use, type of drug, effect of oral environment on drug stability, relationship between concentration and contact duration, effect of biofilm on drug concentration, and local drug use in an initial therapy and after active phase of treatment. It will be information for dentist to use the local drug as an adjunctive treatment of periodontitis.
1. Thomas E, Slots J. Local delivery of antimicrobial agents in the periodontal pocket. Periodontol 2000 1996; 10: 139-159.
2. Magnusson I, Linhe J, Yoneyama T, Liljenberg B. Recolonization of a subgingival microbiota following scaling in deep pockets. J Clin Periodontol 1984; 11: 193-207.
3. Slots J, Mashimo P, Levine MJ, Genco RJ. Periodontal therapy in humans. I. Microbiological and clinical effects of a single course of periodontal scaling and root planing, and of adjunctive tetracycline therapy. J Periodontol 1979; 50: 494-509.
4. Mousques P, Listgarten MA, Phillips RW. Effect of scaling and root planing on the composition of the human subgingival microbial flora. J Periodont Res 1980; 15: 144-151.
5. Sbordone L, Ramaglia L, Gulleta E, Iacono V. Recolonization of the subgingival microflora after scaling and root planing in human periodontitis. J Periodontol 1990; 61: 579- 584.
6. Dibart S, Socransky SS, Haffajee AD, Lai CH, Eftimiadi C. Detection of Bacteroides forsythus in epithelial periodontal pockets. J Dent Res 1995; 74: 226 Abstr 1713.
7. Naito Y, Gibbons RJ. Attachment of Bacteroides gingivalis to collagenous substrata. J Dent Res 1988; 67:1075-1080.
8. Adriaens PA, DeBoever JA, Loesche WJ. Bacterial invasion in root cementum and radicular dentin of periodontally diseased teeth in humans. A reservoir of periodontopathic bacteria. J Periodontol 1988; 59: 222-230.
9. Mombelli A, Samaranayake LP. Topical and systemic antibiotics in the management of periodontal diseases. Int Dent J 2004; 54: 3-14.
10. Goodson JM. Antimicrobial strategies for treatment of periodontal diseases. Periodontol 2000 1994; 5: 142-168.
11. Nagy E, Folders J, Inactivation of metronidazole by Enterococcus faecalis. J Antimicrob Chemother 1991; 27: 63-70.
12. Goodson JM. Pharmacokinetic Principles controlling Efficacy of Oral Therapy. J Dent Res 1989; 68(spec Iss): 1625-1632.
13. Caufield PW, Allen DN, Childers NK. In vitro susceptibilities of suspected periodontopathic anaerobes as determined by membrane transfer assay. Antimicrob Agents Chemother 1987; 58: 529-539.
14. Marsh PD. Plaque as a biofilm: pharmacological principles of drug delivery and action in the sub- and supragingival environment. Oral Diseases 2003; 9 (Supp.I): 16-22.
15. Shani S, Friedman M, Steiberg D. The anticariogenic effect of amine fluorides on Streptococus sorbinus and glucosyl transferase in biofilm. Caries Res 2000; 34: 260-264.
16. Van Strydonck DA, Demoor P, Timmerman MF, van der Velden U, van der Weijden GA. The anti-plaque efficacy of a chlorhexidine mouthrinse used in combination with toothbrushing with dentifrice. J Clin Periodontol 2004; 31: 691-695.
17. Franco Neto CA, Parolo CC, Rosing CK, Maltz M. Comparative analysis of the two chlorhexidine mouthrinses on plaque accumu-lation and gingival bleeding. Braz Oral Res 2008; 22: 139-144.
18. Pizzo G, Guiglia R, Imbrugia M, Pizzo I, D’ Angelo M, Giuliana G. The effects of antimicrobial sprays and mouthrinse on supragingival plaque regrowth: a comparative study. J Periodontol 2006; 77: 248-256.
19. Gjermo P, Saxton CA. Antimicrobial dentifrices.Clinical data and relevance with emphasis on zinc/triclosan. J Clin Periodontol 1991; 18: 468-473.
20. Gordon JM, Lamster IB, Seiger MC. Efficacy of Listerine antiseptic in inhibiting the development of plaque and gingivitis. J Clin Periodontol 1985; 12: 697-704.
21. DePaola LG, Overholser CD, Meiller TF, Minah GE, Niehaus C. Chemotherapeutic inhibition of supragingival dental plaque and gingivitis development. J Clin Periodontol 1989; 16: 311-315.
22. Overholser CD, Meiller TF, Minah GE Niehaus C. Comparative effets of 2 chemotherapeutic mouthrinses on the development of suprsgingival dental plaque and gingivitis. J Clin Periodontol 1990; 17: 575-579.
23. Charles CH, Sharma NC, Galustians HJ, Qaqish J, McGuire JA, Vincent JW. Comparative efficacy of an antiseptic mouthrinse and an antiplaque/antigingivitis dentifrice: a six-month clinical trial. J Am Dent Assoc 2001; 132: 670-675.
24. Charles CH, Mostler KM, Bartels LL, Mankodi SM. Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-mouth clinical trial. J Clin Periodontol 2004; 31: 878- 884.
25. Sharma N, Charles CH, Lynch MC, et al. Adjunctive benefit of an essential oilcontaining mouthrinse in reducing plaque and gingivitis in patients who brush and floss regularly: a six-month study. J Am Dent Assoc 2004; 135: 496-504.
26. Pizzo G, La Cara M, Licata ME, Pizzo I, D’ Angelo M. The effects of an essential oil and an amine fluoride/stannous fluoride mouthrinse on supragingival plaque. J Periodontol 2008; 79: 1177-1183.
27. Marsh PD.Dentifrices containing new agents for the control of plaque and gingivitis: microbiological aspects. J Clin Periodontol 1991; 18: 462-467.
28. Volpe AR, Petrone ME, DeVizio W, Davies RM. A review of plaque, gingivitis, calculus and caries clinical efficacy studies with a dentifrice containing triclosan and PVM/MA copolymer. J Clin Dent 1993; 4(spec issue): 31-41.
29. Christersson LA, Norderyd OM, Puchalsky CS. Topical application of tetracycline HCl in human periodontitis. J Clin Periodontol 1993; 20: 88-95.
30. Goodson JM, Cugini MA, Kent RL et al. Multicenter evaluation of tetracycline fiber therapy. J Periodont Res 1991; 26: 361-379.
31. Drisko CH. Review: Non-surgical pocket therapy: phamacotherapeutics. Annals of Periodontology 1996; 1: 491-566.
32. Pedrazzoli V, Kilian M, Karring T. Comparable clinical and microbiological effects of topical subgingival application of a 25% metronidazole gel and scaling in the treatment of adult periodontitis. J Clin Periodontol 1992; 19: 715-722.
33. Addy M, Langeroudi M. Comparison of the immediate effects on the sub-gingival microflora of acrylic strips containing 40% chlorhexidine, metronidazole or tetracycline. J Clin Periodontol 1984; 11: 379-386.
34. Haffajee AD, Socransky SS. Microbial etiological agents of destructive periodontal diseases. Periodontol 2000 1994; 5: 78-111.
35. van Winkelhoff AJ, Rams TE, Slots J. Systemic antibiotic therapy in periodontics. Periodontol 2000 1996; 10: 45-78.
36. Unsal E, Walsh TF, Akkaya M. The effect of a single application of subgingival antimicrobial or mechanical therapy on the clinical parameters of juvenile periodontitis. J Periodontol 1995; 66: 47-51.
37. Purucker P, Mertes H, Goodson JM, Bernimoulin JP. Local versus systemic adjunctive antibiotic therapy in 28 patients with generalized aggressive periodontitis. J Periodontol 2001; 72: 1241-1245.
38. Greenstein G, Polson A. The role of local drug delivery in the management of periodontal diseases: a comprehensive review. J Periodontol 1998; 69: 507-520.
39. van Steenberghe D, Rosling B,Soder PO et al. 15- month evaluation of the effects of repeated subgingival minocycline in chronic adult periodontitis. J Periodontol 1999; 70: 657- 667.
40. Yeom HR, Park YJ, Lee SJ, Rhyu IC, Chung CP, Nisengard RJ. Clinical and microbiological effects of minocycline-loaded microcapsules in adult periodontitis. J Periodontol 1997; 68: 1102-1109.
41. Drisko CL, Cobb CM, Killoy WJ et al. Evaluation of periodontal treatments using controlled-release tetracycline fibers: clinical response. J periodontol 1995; 66: 692-699.
42. Mombelli A, Tonetti M, LehamannB, Lang NP. Topographic distribution of blackpigmenting anaerobes before and after periodontal treatment by local delivery of tetracycline. J Clin Periodontol 1996; 23: 906- 913.
43. van Steenberghe D, Bercy P, Kohl J et al. Subgingival minocycline hydrochloride ointment in moderate to severe chronic adult periodontitis: A randomized, double-blind, vehicle-controlled, multicenter study. J Periodontol 1993; 64: 637-644.
44. Radvar M, Pourtaghi N, Kinane DF. Comparison of 3 periodontal local antibiotic therapies in persistent periodontal pockets. J periodontol 1996; 67: 860-865.
45. Kinane DF, Radvar M. A six-month comparison of three periodontal local antimicrobial therapies in persistent periodontal pockets. J Periodontol 1999; 70: 1-7.
46. Aimetti M, Romano F, TortaI, Cirilo D, Caposio P, Romagnoli R. Debridement and local application of tetracycline-loaded fibres in the management of persistent periodontitis: results after 12 months. J Clin Periodontol 2004; 31: 166-172.
47. Goldman HM. Periodontal disease, part II: Histologic changes seen in periodontium. Compend Contin Educ Dent 1986; 7: 136-137, 140-144.
48. Maze GI, Reinhardt RA, Agawal RK, Dyer JK, Robinson DH, DuBois LM, Tussing GJ, Maze CR. Response to intracrevicular controlled delivery of 25% tetracycline from poly (lactide/glycolide) film strips in SPT patients. J Clin Periodontol 1995; 22: 860- 867.
49. Tonetti MS, Cortellini P, Carnavale G, Cattabriga M, de Sanctis M, PIni Prato GP. A controlled multicenter study of adjunctive use of tetracycline periodontal fibers in mandibular class II furcations with persistent bleeding. J Clin Periodontol 1998; 25: 728- 736.
50. Newman MG, Kornman KS, Doherty FM. A 6-month multicenter evaluation of adjunctive tetracycline fiber therapy used in conjunction with scaling and root planing in maintenance patients: clinical results. J Periodontol 1994; 65: 685-691.
51. Garrett S, Adams DF, Bogle G et al. The effect of locally delivered controlled-release doxycycline or scaling and root planing on periodontal maintenance patients over 9 months. J Periodontol 2000; 71: 22-30.
52. Heijl L, Dahlen G, Sundin Y, Wenander A, Goodson GM. A 4-quadrant comparative study of periodontal treatment using tetracyclinecontaining drug delivery fibers and scaling. J Clin Periodontol 1991; 18: 111-116.
53. Minabe M, Takeuchi K, Nishimura T, Hori T, Umemoto T. Therapeutic effects of combined treatment using tetracycline-immobilized collagen film and root planning in periodontal furcation pockets. J Clin Periodontol 1991; 18: 287-290.
54. Jones AA, Kornman KS, Newbold DA, Manwell MA. Clinical and microbiological effects of controlled-release locally delivered minocycline in periodontitis. J Periodontol 1994; 65: 1058-1066.
55. Mombelli A, Lehmann B, Tonetti M, Lang NP. Clinical response to local delivery of tetracycline in relation to overall and local periodontal conditions. J Clin Periodontol 1997; 24: 470-477.
56. Morrison SL, Cobb CM, Kazakos M,Killoy W. Root surface characteristics associated with subgingival placement of monolithic tetracycline-impregnated fibers. J Periodontol 1992; 63: 137-143.
57. Killoy WJ, Polson AM. Controlled local delivery of antimicrobials in the treatment of periodontitis. Dent Clin of Notrh America 1998; 42: 263-283.